Oncternal Therapeutics(ONCT) - 2023 Q4 - Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2023 Results Conference Call March 7, 2024 5:00 PM ET Carl Byrnes - Northland Capital Markets Hartaj Singh - Oppenheimer Kemp Dolliver - Brookline Capital Markets Richard Vincent Dr. James Breitmeyer With respect to upcoming milestones, we remain on track. For ONCT-534, our lead DAARI product candidate, we expect to present initial clinical data late in the second quarter of 2024 with additional data readouts in the fourth quarter of 2024. For ONCT-808, our ROR1 ...